YOLFTbeta
00

Zhejiang Jingxin Pharmaceutical Co Ltd

002020 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

11.56CNY-0.24 (-2.03%)

Price History

Full chart

Market Stats

Previous Close11.80
Open11.76
Day Range11.52 – 11.85
52-Week Range11.11 – 21.05
Volume7.55M
Market Cap10.19B
P/E (TTM)13.29
Forward P/E56.18
EPS0.89
Dividend Yield2.96%
Beta-0.18
50-Day Avg12.94
200-Day Avg15.01

About

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactate, levofloxacin hemihydrate, levofloxacin hydrochloride, levofloxacin lactate, enrofloxacin, enrofloxacin hydrochloride, simvastatin, rosuvastatin calcium, pitavastatin calcium, ticagrelor, rivaroxaban, apixaban, cisapride, levetiracetam, brivaracetam, sertraline HCI, rivastigmine bitartrate, pramipexole dihydrochloride, memantine hydrochloride, empagliflozin, dapagliflozin, marbofloxacin, and moxifloxacin. It also provides intermediates; and medical display products, such as diagnostic medical displays, endoscopy, surgical medical displays, clinical medical displays, medical large screens, medical integrated machines, medical imaging solutions, ultrasonic medical displays, and other products. The company was formerly known as Zhejiang Jingxin Pharmaceutical Factory and changed its name to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000. Zhejiang Jingxin Pharmaceutical Co., Ltd. was founded in 1990 and is headquartered in Xinchang, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Lv Gang
  • Employees3.73K
  • HeadquartersNo. 800, Xinchang Avenue East Road, Xinchang, China, 312500, China
  • Websitehttps://www.jingxinpharm.com

Leadership

  • Mr. Lv GangPresident & Chairman of the Board · b. 1962
  • Ms. Chen MeiliVP & CFO · b. 1970
  • Mr. Yunfei HongSecretary of the Board & Non-Independent Director · b. 1980
  • Mr. Sheng LiuVice President · b. 1976
  • Ye Zhen ZhouAccounting Supervisor
  • Mr. Jun Min WangVice President · b. 1973

Financials

Income Statement

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue227.05M269.95M301.51M348.22M301.88M432.59M565.22M510.31M531.47M631.02M709.73M857.58M974.43M1.24B1.42B1.88B2.22B2.94B3.65B3.26B3.47B3.78B4.00B4.16B4.07B
Growth (%)-+18.90%+11.69%+15.49%-13.31%+43.30%+30.66%-9.72%+4.15%+18.73%+12.47%+20.83%+13.62%+26.79%+14.59%+32.48%+18.32%+32.66%+23.88%-10.66%+6.40%+9.04%+5.79%+3.99%-2.14%
Cost of Revenue185.92M208.90M220.84M261.42M204.59M310.74M439.04M361.26M367.28M442.41M522.43M560.03M575.24M659.20M699.29M866.60M917.38M1.04B1.28B1.28B1.55B1.77B1.99B2.10B2.03B
Gross Profit41.13M61.06M80.66M86.80M97.29M119.07M126.18M149.04M164.20M188.61M187.30M297.55M399.18M576.29M716.40M1.01B1.30B1.91B2.36B1.98B1.92B2.01B2.01B2.06B2.04B
Gross Margin18.12%22.62%26.75%24.93%32.23%27.53%22.32%29.21%30.89%29.89%26.39%34.70%40.97%46.64%50.60%53.79%58.66%64.72%64.84%60.80%55.39%53.06%50.30%49.56%50.15%
Operating Expense26.33M35.45M48.65M54.46M61.03M103.28M111.24M169.37M160.32M160.33M157.56M251.59M336.21M451.90M530.31M786.49M1.18B1.49B1.76B1.22B1.22B1.25B1.30B1.22B1.20B
Operating Income14.81M25.60M32.01M32.34M36.26M15.80M14.93M-20.33M3.88M28.28M29.75M45.96M62.98M124.40M186.09M222.38M118.74M415.42M602.06M765.39M698.05M756.62M714.06M843.61M844.79M
Operating Margin6.52%9.48%10.62%9.29%12.01%3.65%2.64%-3.98%0.73%4.48%4.19%5.36%6.46%10.07%13.14%11.86%5.35%14.11%16.51%23.49%20.14%20.02%17.86%20.29%20.76%
EBITDA19.40M31.75M42.82M48.38M43.39M52.67M52.82M65.39M70.72M71.65M97.77M86.95M113.56M167.90M219.26M303.07M336.93M465.34M592.21M642.51M713.89M766.56M784.87M989.48M1.16B
EBITDA Margin8.55%11.76%14.20%13.89%14.37%12.17%9.35%12.81%13.31%11.35%13.78%10.14%11.65%13.59%15.49%16.16%15.18%15.81%16.24%19.72%20.59%20.28%19.63%23.79%28.40%
Net Income9.97M22.28M25.40M25.79M18.45M14.03M1.50M-17.73M3.75M12.90M29.12M31.68M64.35M107.08M166.04M199.75M264.38M369.28M520.40M653.07M612.54M662.25M618.90M711.96M757.98M
Net Income Margin4.39%8.25%8.43%7.41%6.11%3.24%0.27%-3.47%0.71%2.04%4.10%3.69%6.60%8.67%11.73%10.65%11.91%12.54%14.27%20.04%17.67%17.52%15.48%17.12%18.63%
R&D---------14.91M15.83M37.77M42.80M53.83M74.42M110.31M164.30M242.02M254.10M259.24M334.67M367.06M400.93M383.48M367.99M
R&D as % of Total Revenue---------2.36%2.23%4.40%4.39%4.36%5.26%5.88%7.40%8.22%6.97%7.96%9.65%9.71%10.03%9.22%9.04%
Interest Expense4.00M3.74M4.54M4.94M5.27M11.81M22.54M38.06M23.40M18.99M22.08M16.20M13.38M6.21M9.05M9.80M1.43M6.75M12.40M7.68M6.71M7.75M9.88M9.73M3.96M
Interest Expense % of Total Revenue1.76%1.39%1.51%1.42%1.75%2.73%3.99%7.46%4.40%3.01%3.11%1.89%1.37%0.50%0.64%0.52%0.06%0.23%0.34%0.24%0.19%0.20%0.25%0.23%0.10%

Balance Sheet

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets152.50M182.37M258.80M465.14M568.91M772.85M1.02B953.08M917.22M949.15M1.19B1.30B1.32B2.06B2.94B3.29B4.90B4.99B5.63B5.67B6.42B7.36B7.99B8.48B8.12B
Total Liabilities111.83M119.35M170.36M181.11M279.27M478.23M716.18M649.89M610.06M629.02M426.39M528.40M506.65M666.12M679.39M864.23M938.43M1.42B1.91B1.73B1.58B2.19B2.45B2.48B2.25B
Total Equity40.67M63.02M88.44M279.53M282.64M293.14M298.18M299.29M303.04M315.94M766.17M772.58M817.98M1.40B2.22B2.38B3.92B3.56B3.70B3.92B4.82B5.15B5.51B5.97B5.83B
Cash4.29M15.05M21.98M77.66M67.97M106.59M228.74M227.61M222.82M102.31M321.90M312.92M197.46M380.12M432.61M261.71M333.55M410.87M493.22M915.35M1.55B1.55B1.46B316.27M530.71M
Total Debt34.75M61.79M90.06M65.06M132.06M231.50M390.00M398.00M312.30M383.96M265.37M226.45M136.04M39.15M51.84M200.00M185.57M150.00M359.40M300.77M168.46M296.30M310.32M304.49M-
Net Debt30.46M46.73M68.08M-12.60M64.09M124.91M161.26M170.39M89.48M281.65M-56.53M-86.47M-61.42M-340.96M-380.77M-61.71M-147.98M-260.87M-133.81M-614.58M-1.39B-1.25B-1.15B-11.78M-

Cash Flow

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-45.50M46.18M6.43M61.82M-1.45M-87.60M29.98M135.38M59.55M69.41M60.28M111.03M210.49M144.69M252.69M385.01M523.40M535.30M513.21M365.02M855.78M824.69M726.16M781.35M
Investing Cash Flow--45.49M-74.69M-98.10M-133.05M-96.62M2.68M-11.47M-2.39M-145.95M-88.83M-82.60M-106.66M-492.51M-316.45M-423.75M-1.30B-172.19M-214.21M463.93M144.69M-737.66M-769.45M-1.44B-
Financing Cash Flow-23.27M25.60M143.04M50.16M104.51M109.02M-41.15M-109.30M62.47M281.89M-120.52M-66.50M371.36M228.09M88.51M993.34M-278.05M-226.34M-497.38M120.85M-188.03M-245.61M-280.16M-
Capital Expenditure047.79M71.19M98.11M134.67M91.30M54.85M43.81M20.18M155.87M71.86M83.51M108.28M94.75M114.31M95.26M112.19M242.19M337.33M334.00M404.43M515.57M519.51M250.65M202.85M
Free Cash Flow--2.30M-25.01M-91.68M-72.85M-92.75M-142.44M-13.83M115.20M-96.32M-2.45M-23.23M2.75M115.74M30.39M157.43M272.82M281.21M197.97M179.21M-39.41M340.20M273.32M475.52M578.50M
Dividends Paid-3.99M4.76M5.00M18.66M11.54M17.65M38.55M23.60M18.64M22.54M41.45M31.99M30.45M50.31M49.84M63.98M142.81M205.85M231.94M231.43M258.31M258.31M258.31M284.85M
FCF to OCF--5.05%-54.17%-1425.69%-117.84%6414.17%162.62%-46.12%85.09%-161.75%-3.52%-38.55%2.48%54.99%21.00%62.30%70.86%53.73%36.98%34.92%-10.80%39.75%33.14%65.48%74.04%
Dividend Paid to FCF--173.90%-19.02%-5.45%-25.61%-12.44%-12.39%-278.76%20.49%-19.35%-921.60%-178.42%1162.08%26.31%165.57%31.66%23.45%50.78%103.98%129.43%-587.23%75.93%94.51%54.32%49.24%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Jul 31, 2014Oct 27, 2014Feb 27, 2015Apr 27, 2015Jul 30, 2015Oct 29, 2015Feb 27, 2016Apr 21, 2016Aug 17, 2016Oct 26, 2016Apr 26, 2017Aug 23, 2017Oct 22, 2017Apr 24, 2018Jul 20, 2018Oct 22, 2018Apr 26, 2019Jul 25, 2019Oct 24, 2019Feb 26, 2020Apr 17, 2020Aug 24, 2020Oct 27, 2020Feb 26, 2021Apr 26, 2021Aug 26, 2021Oct 27, 2021Feb 25, 2022Apr 26, 2022Aug 25, 2022Oct 27, 2022Mar 29, 2023Apr 25, 2023Aug 14, 2023Oct 26, 2023Mar 29, 2024Apr 23, 2024Aug 14, 2024Oct 25, 2024Apr 2, 2025Aug 27, 2025Oct 30, 2025Apr 27, 2026Aug 27, 2026
EPS Estimate------------------0.050.03-0.070.070.09---0.090.090.09-------------------------------
EPS Actual0.000.010.010.010.010.020.020.010.010.020.020.010.020.030.030.020.040.060.060.020.060.100.090.040.080.100.080.040.040.040.120.180.180.030.240.200.030.110.170.170.440.200.170.200.210.160.190.200.220.180.190.180.170.200.270.200.160.280.230.200.23
Surprise------------------20.00%-33.33%-42.86%28.57%-55.56%----55.56%-55.56%-55.56%-------------------------------
Timing-----------------Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-market-Pre-market----

Key Statistics & Ratios

Market Cap10.19B
Enterprise Value9.15B
Trailing P/E13.29
Forward P/E56.18
PEG Ratio2.68
Price / Sales2.52
Price / Book1.68
EPS0.89
Book Value7.31
Revenue (TTM)4.04B
Gross Profit (TTM)1.99B
EBITDA1.02B
Profit Margin17.86%
Operating Margin21.35%
Return on Equity12.67%
Return on Assets6.10%
Shares Outstanding861.03M
Shares Float456.86M
Beta-0.18
Dividend Yield2.96%
Dividend Rate0.35
Payout Ratio52.97%

Dividends

20261×
0.35Jun 11, 2026
20251×
0.35May 29, 2025
20241×
0.30May 24, 2024
20231×
0.30May 24, 2023
20221×
0.30May 25, 2022
20211×
0.29May 28, 2021
20201×
0.29Jun 1, 2020
20191×
0.25May 29, 2019
20181×
0.17Jun 8, 2018
20171×
0.08Jun 23, 2017
20161×
0.06May 23, 2016
20151×
0.06Jul 7, 2015
20141×
0.04May 23, 2014
20131×
0.03May 27, 2013
20121×
0.04Jul 6, 2012
20051×
0.03May 16, 2005

Stock Splits

  • May 28, 20211.2:1
  • May 23, 201620:10
  • May 27, 201320:10
  • Nov 9, 200513.8:10